Literature DB >> 6784974

2-Mercaptoethanesulfonate-cysteine disulfide excretion following the administration of 2-mercaptoethanesulfonate--a pitfall in the diagnosis of sulfite oxidase deficiency.

M Duran, G Aarsen, R H Fokkens, N M Nibbering, B P Cats, P K de Bree, S K Wadman.   

Abstract

In the urine of a neonate with respiratory insufficiency and convulsions a positive sulfite reaction was found, which is suggestive of sulfite oxidase deficiency. The nitroprusside reaction also was positive. More detailed investigations showed that both tests were positive due to the administration of 2-mercaptoethanesulfonate, a mucolytic drug. The patient's urine contained an acidic amino acid with a column chromatographic behaviour like S-sulfocysteine. The high-voltage electrophoretic mobility was slightly different. This compound was isolated from the urine and identified as the mixed disulfide of 2-mercaptoethanesulfonate and cysteine. Its identity was proven with field desorption mass spectrometry, a technique which is suitable for the analysis of sulfonic acid derivatives.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6784974     DOI: 10.1016/0009-8981(81)90419-8

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  8 in total

1.  A new case of isolated sulphite oxidase deficiency with rapid fatal outcome.

Authors:  C Vianey-Liaud; P Desjacques; J Gaulme; C Dorche; P Vanlieferinghen; P Dechelotte; P Divry
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

2.  Isolated sulphite oxidase deficiency mimics the features of hypoxic ischaemic encephalopathy.

Authors:  Emma E Hobson; Sumesh Thomas; Patricia M Crofton; Alison D Murray; John C S Dean; David Lloyd
Journal:  Eur J Pediatr       Date:  2005-07-16       Impact factor: 3.183

3.  Pharmacokinetics of intravenous and oral sodium 2-mercaptoethane sulphonate (mesna) in normal subjects.

Authors:  C A James; T G Mant; H J Rogers
Journal:  Br J Clin Pharmacol       Date:  1987-05       Impact factor: 4.335

4.  Oral bioavailability of mesna tablets.

Authors:  B Stofer-Vogel; T Cerny; M Borner; B H Lauterburg
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

5.  Depletion of total cysteine, glutathione, and homocysteine in plasma by ifosfamide/mesna therapy.

Authors:  B H Lauterburg; T Nguyen; B Hartmann; E Junker; A Küpfer; T Cerny
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

Review 6.  Ifosfamide clinical pharmacokinetics.

Authors:  T Wagner
Journal:  Clin Pharmacokinet       Date:  1994-06       Impact factor: 6.447

7.  Depletion of circulating cyst(e)ine by oral and intravenous mesna.

Authors:  B Stofer-Vogel; T Cerny; A Küpfer; E Junker; B H Lauterburg
Journal:  Br J Cancer       Date:  1993-09       Impact factor: 7.640

8.  Case Report: Electroencephalography in a neonate with isolated sulfite oxidase deficiency - a case report and literature review.

Authors:  Andreea M Pavel; Carol M Stephens; Sean R Mathieson; Brian H Walsh; Brian McNamara; Niamh McSweeney; Geraldine B Boylan
Journal:  HRB Open Res       Date:  2021-11-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.